Thrombin-generating capacity in patients with von Willebrand's disease

被引:54
作者
Rugeri, Lucia [1 ,2 ]
Beguin, Suzette [3 ]
Hemker, Coenraad [3 ]
Bordet, Jean-Claude [2 ,4 ]
Fleury, Raphael [1 ]
Chatard, Brigitte [2 ]
Negrier, Claude [1 ,2 ,4 ]
Dargaud, Yesim [1 ,2 ,4 ]
机构
[1] Hop Edouard Herriot, Unite Hemostase Clin, Pavillon E 5,Pl Arsonval, F-69003 Lyon, France
[2] Hop Edouard Herriot, Lab Hemostase, Lyon, France
[3] Univ Maastricht, Synapse Bv, CARIM, Maastricht, Netherlands
[4] Univ Lyon 1, EA 3735, Lyon, France
关键词
von Willebrand's disease; factor VIII; thrombin generation assay; bleeding phenotype; von Willebrand factor;
D O I
10.3324/haematol.11460
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives von Willebrand's disease (VWD) is the most common hereditary bleeding disorder. Its severity can be classified on the basis of von Willebrand factor (VWF) and factor VIII (FVIII) plasma levels and according to the clinical relevance of bleeding episodes. However, patients with very low VWF activity may exhibit a mild bleeding tendency. The basis for this heterogeneous clinical expression of the deficit is still poorly understood. We investigated the relationship between thrombin generation and levels of factor VIII, VWF and clinical bleeding tendency. Design and Methods Thrombin generation was measured in platelet-rich (PRP) and platelet-poor plasma (PPP) from 53 patients with VWD. Results We observed a statistically significant higher risk of bleeding in patients with a low thrombin peak in PRP (OR=14.5; 95% CI=5-41.3). Similar results were found in PPP (OR=8.71; 95% CI=3.4-22.3). Two parameters of the thrombin generation curve, peak height and thrombin generation speed (slope), correlated significantly with VWF:RCo and FVIII levels both in PPP and in PRP Regression analysis showed that thrombin generation was mainly dependent on plasma FVIII activity. Interpretation and Conclusions Our results suggest that the thrombin generation test, in combination with routine FVIII and VWF measurements, could be of interest in the assessment of the individual bleeding risk in patients with VWD.
引用
收藏
页码:1639 / 1646
页数:8
相关论文
共 50 条
  • [1] Haemophilia A and von Willebrand's disease
    Goodeve, A. C.
    Rosen, S.
    Verbruggen, B.
    HAEMOPHILIA, 2010, 16 : 79 - 84
  • [2] Treatment of von Willebrand's disease
    Mannucci, PM
    JOURNAL OF INTERNAL MEDICINE, 1997, 242 : 129 - 132
  • [3] von Willebrand’s disease
    R. R. de Gopegui
    B. F. Feldman
    Comparative Haematology International, 1997, 7 : 187 - 196
  • [4] Pharmacotherapy of von Willebrand disease
    Franchini, Massimo
    Lippi, Giuseppe
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (06): : 481 - 489
  • [5] Von Willebrand's disease
    Ewenstein, BM
    ANNUAL REVIEW OF MEDICINE, 1997, 48 : 525 - 542
  • [6] Platelets compensate for poor thrombin generation in type 3 von Willebrand disease
    Szanto, Timea
    Nummi, Vuokko
    Jouppila, Annukka
    Brinkman, Herm Jan M.
    Lassila, Riitta
    PLATELETS, 2020, 31 (01) : 103 - 111
  • [7] Von Willebrand's Disease
    Leebeek, Frank W. G.
    Eikenboom, Jeroen C. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21) : 2067 - 2080
  • [8] Von Willebrand's disease
    Dietrich, Jennifer E.
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2007, 20 (03) : 153 - 155
  • [9] The problem of diagnosing von Willebrand's disease
    Batlle, J
    Torea, J
    Rendal, E
    Fernandez, MFL
    JOURNAL OF INTERNAL MEDICINE, 1997, 242 : 121 - 128
  • [10] Prophylaxis and von Willebrand's disease (vWD)
    Abshire, Thomas C.
    THROMBOSIS RESEARCH, 2006, 118 : S3 - S7